KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Asset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionExchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Twist Bioscience (TWST) Amortizatization of Intangibles (2017 - 2022)

Twist Bioscience (TWST) has disclosed Amortizatization of Intangibles for 6 consecutive years, with $1.2 million as the latest value for Q3 2022.

  • On a quarterly basis, Amortizatization of Intangibles rose 13.43% to $1.2 million in Q3 2022 year-over-year; TTM through Sep 2023 was $14.2 million, a 0.03% change, with the full-year FY2023 number at $5.9 million, down 58.49% from a year prior.
  • Amortizatization of Intangibles was $1.2 million for Q3 2022 at Twist Bioscience, down from $13.9 million in the prior quarter.
  • In the past five years, Amortizatization of Intangibles ranged from a high of $13.9 million in Q2 2022 to a low of -$794000.0 in Q1 2022.
  • A 5-year average of $864578.9 and a median of $77000.0 in 2018 define the central range for Amortizatization of Intangibles.
  • Peak YoY movement for Amortizatization of Intangibles: crashed 1800.0% in 2021, then skyrocketed 7512.3% in 2022.
  • Twist Bioscience's Amortizatization of Intangibles stood at $78000.0 in 2018, then soared by 92.31% to $150000.0 in 2019, then plummeted by 80.0% to $30000.0 in 2020, then crashed by 86.67% to $4000.0 in 2021, then soared by 29250.0% to $1.2 million in 2022.
  • Per Business Quant, the three most recent readings for TWST's Amortizatization of Intangibles are $1.2 million (Q3 2022), $13.9 million (Q2 2022), and -$794000.0 (Q1 2022).